CHRISTOPHER TAYLOR: Open Payments
NPI 1851747166 · MENIFEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 21 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $100 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| ViiV Healthcare Company | 2 | $52 |
| Novo Nordisk Inc | 2 | $46 |
| Exact Sciences Corporation | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Dexcom, Inc. | 1 | $17 |
Products named: Kerendia, APRETUDE, Cologuard Collection Kit, Epclusa, MOUNJARO, Wegovy, Dexcom G6 Transmitter, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
